A Norwegian Swedish clinical trial published in the New England Journal of Medicine (NEJM) demonstrates that rituximab, a low-cost B-cell depleting therapy, is as effective as ocrelizumab in newly diagnosed relapsing multiple sclerosis (MS).

2 Jul 2026

Paracetamol during pregnancy does not raise autism or ADHD risk

A sibling-matched study finds no link between prenatal paracetamol use and autism or ADHD, reassuring its safety when clinically indicated during pregnancy.

2 Jul 2026

ACMG issues guidance for reporting uncertain genetic test variants

The American College of Medical Genetics and Genomics (ACMG) has published a new statement, Points to Consider for the Reporting of Variants of Uncertain Significance in Germline Genetic and Genomic Testing, providing guidance to laboratories and healthcare professionals on the reporting and communication of variants of uncertain significance (VUS) identified through genetic and genomic testing.

1 Jul 2026

New safety strategies reduced serious surgical events in children

Ann & Robert H. Lurie Children's Hospital of Chicago achieved more than a 13-fold improvement in surgical safety after implementing a series of interventions based on high reliability principles across its operating rooms.

1 Jul 2026

Blood pressure and cholesterol gaps shrink among older adults with obesity

Over the last three decades, differences in unhealthy cholesterol levels and blood pressure between older adults with obesity and those with a normal Body Mass Index (BMI) have narrowed or disappeared in several high-income countries, suggests a study published in The Lancet.

1 Jul 2026

Scientists urge caution over psychedelics as ADHD treatment

In recent years, there has been growing interest among adults with ADHD in the practice of microdosing classic psychedelics such as psilocybin and LSD.

1 Jul 2026

Collaboration shapes the future of personalized medicine innovation

The development of personalized medicine depends on collaboration between multiple stakeholders, who must navigate uncertainty while shaping expectations of future value.

1 Jul 2026

EULAR project reveals large disparities in European rheumatology care

Rheumatic and musculoskeletal diseases (RMD) are responsible for significant disability, and result in long-term work loss or early retirement.

1 Jul 2026

Alzheimer’s disease biomarkers predict rapid cognitive decline in very old adults

Cognitive decline in very old adults has been considered for decades to be an almost inevitable consequence of aging.

1 Jul 2026

New national program targeting harmful and unnecessary medicine use in Australia

...

1 Jul 2026

GLP-1 medications may improve long-term health for people with peripheral artery disease

GLP-1 receptor agonists (GLP-1 RA) medications were shown to reduce the number of deaths, amputations and hospitalizations among people with Type 2 diabetes who also had narrowed leg arteries associated with PAD (peripheral artery disease), according to new, independent research published today in the Journal of the American Heart Association, an open-access, peer-reviewed journal of the American Heart Association.

1 Jul 2026

Obesity may account for up to one in four polypharmacy cases

The study reveals obesity's role in polypharmacy, indicating that reducing obesity may lower medication burden and enhance quality of life for older adults.

1 Jul 2026

New soft robotic heart accurately mimics the complex movements of human valves

Researchers at UNSW Sydney have developed a fully synthetic soft robotic heart that reproduces the complex movements and internal structures of the human heart, opening the door to better treatments, safer medical devices and more personalized care.

1 Jul 2026

Study links semaglutide and tirzepatide to fewer anxiety and depression diagnoses in obesity care

A US electronic health record study found that adults with obesity who started semaglutide or tirzepatide had lower recorded hazards of anxiety and depression than matched patients using naltrexone-bupropion. However, among adults without type 2 diabetes, tirzepatide was linked to higher recorded hazards of anxiety and insomnia than semaglutide, underscoring the need for cautious monitoring.

1 Jul 2026

Study links severe COVID to higher TB risk, and vaccination appears to blunt the link

A nationwide Chilean cohort study of more than 3.6 million adults found that severe COVID-19 requiring hospitalization was associated with more than an eightfold higher hazard of incident tuberculosis within one year. The association was strongest in the first six months and among unvaccinated individuals, although absolute TB incidence remained low.

1 Jul 2026

Blood protein clocks flag higher risks of death and chronic disease

Proteomic age clocks applied to two European cohorts linked faster biological aging with smoking, alcohol use, physical inactivity, all-cause mortality, cardiovascular disease, dementia, and several cancers. The Global proteomic clock predicted mortality as well as established lifestyle risk factors, while organ-specific clocks showed stronger links with related cancers of the kidney, lung, and stomach.

30 Jun 2026

Trial evaluates interdisciplinary care for veterans with brain trauma and PTSD

The Medical College of Wisconsin (MCW) is leading a new multi-center clinical trial to evaluate an interdisciplinary rehabilitation model for military veterans and first responders with mild traumatic brain injury (mTBI) and co-occurring disorders such as depression, anxiety, and post-traumatic stress disorder (PTSD).

30 Jun 2026

New trial shows oral therapy increases growth in children with achondroplasia

New findings from a trial conducted at Children's Hospital Colorado (Children's Colorado) and University of Colorado (CU) Anschutz School of Medicine demonstrate significantly increased growth rates in children with achondroplasia, the most common form of dwarfism.

30 Jun 2026

Many pharmaceutical active ingredients can switch to PFAS-free alternatives

Certain medicines contain per- and polyfluorinated alkyl compounds, known as PFAS, which are causing increasing environmental harm due to their long-lasting effects.

30 Jun 2026